Table 1D.
Country (region) | Population (in millions) | COVID-19 cases per million (in thousands) | Deaths due to COVID-19 (per million) |
Wave with more impact on the country | Wave with more impact on NBS | Average number of newborns per country (2015–2020; from 30 June of the initial and final year) | Newborns screened/year/centre | Number of diseases in NBS | Impairment of NBS during the pandemic* | Were there plans/guidelines for NBS during a pandemic |
Asia | ||||||||||
India (South India, Telangana) | 1391.3 | 14.317 | 157 | Both equally | Both equally | 24 237 733 | 6000 | 21–30 | A lot | No |
India (Karnataka) | 1391.3 | 14.317 | 157 | Both equally | None | 24 237 733 | 3000 | 6–10 | Little | No |
Indonesia | 275.9 | 6.078 | 166 | Second | N/A | 4 841 680 | 10 000 | 1–5 | Little | N/A |
Japan (Sapporo) | 126.2 | 4.734 | 82 | First | None | 953 388 | 950 000 | 11–20 | None | No |
Philippines (Davao del Sur) | 110.8 | 9.521 | 157 | Both equally | First | 2 177 879 | 314 687† | 21–30 | Little | No |
Sri Lanka (Southern Sri Lanka) |
21.5 | 5.201 | 32 | Second | Both equally | 339 036 | 160 000 | 1–5 | A lot | No |
Taiwan (Taipei) | 23.9 | 48 | 0.5 | First | First | 199 572 | 55 000 | 31 or more | None | Yes |
Vietnam (Hanoi City) | 98.1 | 30 | 0.4 | First | First | 1 609 918 | ~150 000 | 31 or more | Little | No |
*A 5-point Likert scale was used to determine the impairment (1=none, 2=little, 3=moderate, 4=a lot, 5=a great deal).
†The exact number is given for year 2020.
N/A, not available; NBS, newborn screening.